UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Melco Resorts & Entertainment
MLCO
$2.14B
| $14.2M | ﹤0.01% |
1,904,392
-1,146,977
| -38% | -$8.66M |
|
1952
Invesco Semiconductors ETF
PSI
$2.48B
| $14.2M | ﹤0.01% |
226,099
+25,708
| +13% | +$1.48M |
|
1953
Acadia Healthcare
ACHC
$2.88B
| $14.2M | ﹤0.01% |
210,026
+169,219
| +415% | +$11.8M |
|
1954
Jazz Pharmaceuticals
JAZZ
$16.6B
| $14.2M | ﹤0.01% |
132,789
-31,611
| -19% | -$3.48M |
|
|
ASGI
1955
abrdn Global Infrastructure Income Fund
ASGI
$758M
| $14.1M | ﹤0.01% |
772,319
-33,396
| -4% | -$604K |
|
1956
PUT
Best Buy
BBY
$17.1B
| $14.1M | ﹤0.01% |
167,300
+7,500
| +5% | +$595K |
|
|
HPS
1957
John Hancock Preferred Income Fund III
HPS
$458M
| $14.1M | ﹤0.01% |
891,284
+54,978
| +7% | +$844K |
|
1958
PUT
Trip.com Group
TCOM
$29.1B
| $14M | ﹤0.01% |
298,900
-67,500
| -18% | -$3.44M |
|
1959
Rocket Lab Corp
RKLB
$50.4B
| $14M | ﹤0.01% |
2,925,704
+2,241,764
| +328% | +$9.34M |
|
1960
MasTec
MTZ
$21.1B
| $14M | ﹤0.01% |
130,993
+76,948
| +142% | +$7.77M |
|
1961
Janus Henderson B-BBB CLO ETF
JBBB
$1.41B
| $14M | ﹤0.01% |
284,221
+278,688
| +5,037% | +$13.6M |
|
|
HTD
1962
John Hancock Tax-Advantaged Dividend Income Fund
HTD
$898M
| $14M | ﹤0.01% |
691,285
-8,228
| -1% | -$164K |
|
1963
Regal Rexnord
RRX
$12B
| $14M | ﹤0.01% |
103,293
+2,284
| +2% | +$355K |
|
1964
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.75B
| $14M | ﹤0.01% |
193,897
+67,482
| +53% | +$4.73M |
|
1965
State Street SPDR S&P International Dividend ETF
DWX
$532M
| $14M | ﹤0.01% |
405,346
+2,859
| +0.7% | +$99.7K |
|
1966
CALL
Vanguard FTSE Emerging Markets ETF
VWO
$124B
| $14M | ﹤0.01% |
+318,900
| New | +$13.7M |
|
1967
CALL
iShares US Real Estate ETF
IYR
$4.66B
| $14M | ﹤0.01% |
159,000
-201,000
| -56% | -$17.2M |
|
|
UCTT
1968
Ultra Clean Holdings
UCTT
$3.82B
| $14M | ﹤0.01% |
284,704
-22,496
| -7% | -$1.01M |
|
1969
PUT
Petrobras
PBR
$117B
| $13.9M | ﹤0.01% |
957,856
-822,144
| -46% | -$12.8M |
|
1970
OGE Energy
OGE
$9.74B
| $13.9M | ﹤0.01% |
388,242
+9,043
| +2% | +$317K |
|
1971
Corebridge Financial
CRBG
$15.2B
| $13.8M | ﹤0.01% |
475,357
+258,772
| +119% | +$7.45M |
|
1972
Allegion
ALLE
$14.5B
| $13.8M | ﹤0.01% |
117,113
+2,902
| +3% | +$358K |
|
1973
PUT
AstraZeneca
AZN
$248B
| $13.8M | ﹤0.01% |
88,700
-51,300
| -37% | -$7.72M |
|
1974
iShares iBonds Dec 2033 Term Treasury ETF
IBTO
$463M
| $13.8M | ﹤0.01% |
573,782
-48,731
| -8% | -$1.16M |
|
1975
CALL
British American Tobacco
BTI
$128B
| $13.8M | ﹤0.01% |
445,000
-12,500
| -3% | -$380K |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.